Expertise and advice on analysing real-world data

Harnessing real-world data to enlarge medical knowledge and address quality of care
illustration-expertise-conseil
Expertise

Effective tools for healthcare professionals

pelyon-accueil-image-expertise
pelyon-accueil-icon-etudes-epidemiologiques

Epidemiological studies

pelyon-accueil-icon-etudes-pharmaco-epidemiologiques

Pharmacoepidemiological studies

pelyon-accueil-icon-evaluations

Assessment

pelyon-accueil-icon-etudes-economiques

Economic studies

pelyon-accueil-icon-assistance-conseil

Methodological assistance and advice

Application fields

pelyon-accueil-icon-qualite-soins
Quality of care
pelyon-accueil-icon-usage-medicament
Therapeutic adherence
pelyon-accueil-icon-adhesion
Drug use
pelyon-accueil-icon-etudes-cout-maladie
Cost of illness study
pelyon-accueil-icon-prise-en-charge
Comparison of treatment strategies

News

New publication

12/03/2024
We are pleased to share our new article: Health care resource utilization preceding death or lung transplantation in people with cystic fibrosis HCRU before transplant or death in cystic fibrosis published in Journal of CysticFibrosis. Thanks to the co-authors and to the CNAM for the SNDS data.

ISPOR 2023

25/10/2023
PELyon will be present at ISPOR 2023.   We will be happy to meet you there.

Partnership between LYSARC and PELyon

26/09/2023
PELyon is pleased to announce its agreement with LYSARC for the conduct of research projects based on the linkage of clinical data relating to lymphomas from LYSARC with the SNDS. This partnership aims to carry out research projects between our two structures, but also to collaborate on external projects, in…

We have partnered with healthcare professionals in the pharmaceutical and biomedical industry, healthcare facilities, health authorities, and associations since 2010.

 

Our experience and skills help them to respond appropriately to strategic decisions on healthcare products and programmes including quality of care, adherence, drug use, cost of illness studies, and comparison of treatment strategies.

 

We are a multidisciplinary team made up of doctors, project managers, epidemiologists, biostatisticians and data analysts.

Our values

Independence

We work on projects with a public health interest and are committed to publishing the scientific results obtained.

Reliability

We meet deadlines and never compromise on the quality of our deliverables.

Integrity

We draw up our protocols and conduct our analyses according to epidemiological best practice and established procedures.

ÉVALUER
les fardeaux économiques et cliniques des maladies
COMPARER
des stratégies de prise en charge
Publications

Experience

The public health value of the results of the studies carried out by PELyon is evidenced by their publication in international peer-reviewed scientific journals.

Our partnerships

Agoria3
LOGO_LYSARC_QUADRI (1)
1652272655349

Our partnerships